Kikuchi disease is typically a benign, self-limiting inflammatory process that resolves with supportive measures within months without any specific treatment.Â  The relapse rate is about 3-4% in adults and is treated with corticosteroids, intravenous immunoglobulins, or hydroxychloroquine